Intellectual Property Protection

Intellectual Property Protection

For clients in the food, drug, and consumer product industries, Amin Wasserman Gurnani offers unparalleled depth in intellectual property and FDA regulatory matters. Our team’s expertise in both of these areas, coupled with the added value of being seasoned IP litigators, allows us to become strategic partners with our clients, guiding their products through the pipeline with a vigilant eye on the protection of their intellectual property.

The IP team at Amin Wasserman Gurnani advises companies at every stage of the product lifecycle. We counsel our clients from the beginning of product development through prototype development and clinical trials, with the goal of enhancing product value and gaining FDA approval. We then continue to provide support through eventual patent applications and potential challenges in court or the Patent Office.

Although many of our attorneys are trained scientists, we also leverage our extensive business law experience to help clients realize the full value of their intellectual property rights through licensing agreements, joint ventures, and other distribution programs. We provide comprehensive assistance on issues associated with the acquisition, enforcement and exploitation of intellectual property. When it is necessary to defend challenges before regulatory agencies or in court, our IP litigators are known for their innovative strategies which are increasingly emulated by others in the field. For example, Amin Wasserman Gurnani lawyers acted as lead trial counsel in the groundbreaking case Merck & CIE, et al. v. Gnosis S.p.A., et al. where they achieved the first successful invalidation of several pharmaceutical patents through the new IPR process. This matter was also significant as it was the first time the Federal Circuit affirmed the Patent Trial and Appeal Board’s invalidation of a pharmaceutical patent in the new IPR process.

Our team is focused on the food, beverage, nutritional supplement, cosmetic and drug industries, but also has extensive experience with medical devices, biotechnology, and human and animal life sciences.

More on Patent Protection, Licensing and Freedom to Operate here.

More on Trademark, Brand, Logo and Slogan Protection here.

Practice Group Leader(s)

George R. Spatz


312.784.1062 PHONE

Peter Paredes


312.784.1061 PHONE

George M. Carrera, Jr.

Patent Agent

312.784.3056 PHONE

Ryan Kaiser


312.466.1033 PHONE


Jonathan J. Krit

Of Counsel

312.327.3357 PHONE

Rakesh M. Amin


312.327.3382 PHONE

Ashley Rovner-Watson


312.784.1071 PHONE

Manon Burns


312.784.3018 PHONE